Drug regulator asks Serum Institute to increase safety monitors of Covid drug trials

A day after the company halted the trial of the AstraZeneca-Oxford University Covid vaccine in the country. The Drug controller has asked the Pune based company to suspend any new recruitment in the Phase II/III trial till further orders.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Fqyk6f
via IFTTT